Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Microbiol. 2010 Nov;8(11):827-34. doi: 10.1038/nrmicro2437. Epub 2010 Oct 12.

Nanobead-based interventions for the treatment and prevention of tuberculosis.

Author information

  • 1Department of Molecular Biosciences, University of Oslo, 0316 Oslo, Norway. g.w.griffiths@imbv.uio.no

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the most devastating bacterial diseases to affect humans. M. tuberculosis is a robust pathogen that has evolved the capacity to survive and grow inside macrophage phagosomes. A cocktail of antibiotics has long been successfully used against M. tuberculosis but is becoming less effective owing to the emergence of multidrug resistance. The only available preventive vaccine, using Mycobacterium bovis bacille Calmette-Guérin, is considered to be ineffective against adult pulmonary TB, the most prevalent form of the disease. Here, we review the potential use of biodegradable nanoparticle-based anti-TB drug delivery systems that have been shown to be more effective against M. tuberculosis in animal models than conventional antibiotic treatment regimens. This technology also has substantial potential for vaccination and other therapeutic strategies against TB and other infectious diseases.

PMID:
20938454
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk